DOCSLIB.ORG

Supplementary Table S1. List of All the Proteins Identified by Itraq Analysis

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Supplementary Table S1. List of All the Proteins Identified by Itraq Analysis Supplementary Table S1. List of all the proteins identified by iTRAQ analysis. OVSA OVISE OVMA RMG- JHOS4 OVCA OVSA SKOV Seque OVISE OVMA RMG- JHOS4 OVCA OVSA HO/H SKOV # OVISE /HOSE OVMA NA/HO RMG- I/HOS JHOS4 /HOSE OVCA R3/HO HO/H SKOV 3/HOS Accession nce MW calc. Subcellular /HOSE NA/HO I/HOS /HOSE R3/HO HO/H OSE2 3/HOS Pept # AAs Score Protein name /HOSE 2C NA/HO SE2C I/HOS E2C /HOSE 2C R3/HO SE2C OSE2 3/HOS E2C number covera [kDa] pI localization 2C SE2C E2C 2C SE2C OSE2 C E2C ides 2C Variabi SE2C Variabi E2C Variabi 2C Variabi SE2C Variabi C E2C Variabi ge(%) Count Count Count Count Count C Variabi Count lity [%] lity [%] lity [%] lity [%] lity [%] Count lity [%] lity [%] Extended synaptotagmin-2 OS=Homo sapiens GN=ESYT2 PE=1 SV=1 - Plasma A0FGR8 13.9 10 921 102.29 9.26 421.7 1.043 12 19.8 0.758 9 15.3 0.969 11 43.5 1.080 11 27.3 0.800 10 34.7 3.281 12 74.1 1.430 9 38.6 [ESYT2_HUMAN] membrane A0MZ66 3.65 2 631 71.60 5.33 49.5 Shootin-1 OS=Homo sapiens GN=KIAA1598 PE=1 SV=4 - [SHOT1_HUMAN] Other 2.515 3 33.6 1.495 3 13.1 1.985 2 56.9 1.684 3 5.4 1.561 3 31.4 1.881 3 22.2 2.783 3 32.1 Acetolactate synthase-like protein OS=Homo sapiens GN=ILVBL PE=1 SV=2 - A1L0T0 10.13 5 632 67.82 8.15 231.2 Other 0.820 4 20.3 0.675 4 37.0 0.833 4 37.6 0.880 4 44.3 0.789 4 37.8 3.677 4 78.5 0.929 4 13.0 [ILVBL_HUMAN] Uncharacterized protein KIAA0564 OS=Homo sapiens GN=KIAA0564 PE=1 A3KMH1 1.15 2 1905 214.69 7.40 30.9 Secreted 0.934 1 0.661 1 1.650 2 28.7 1.928 2 18.0 0.949 2 38.8 1.748 2 10.7 2.450 1 SV=2 - [K0564_HUMAN] WD repeat-containing protein 91 OS=Homo sapiens GN=WDR91 PE=1 SV=2 - A4D1P6 1.61 1 747 83.29 6.58 24.7 Other 1.837 1 [WDR91_HUMAN] Putative Rab-43-like protein ENSP00000330714 OS=Homo sapiens PE=5 SV=3 A6NDJ8 12.15 1 181 20.20 6.54 156.1 Nucleus 0.849 1 3.087 1 0.157 1 0.330 1 0.880 1 1.538 1 0.307 1 - [RB43L_HUMAN] Structural maintenance of chromosomes flexible hinge domain-containing protein A6NHR9 1.2 2 2005 226.23 7.30 53.1 Other 0.964 3 39.5 0.777 2 86.9 0.701 2 42.7 0.367 3 8.0 0.523 3 8.5 0.854 3 14.6 1.209 2 58.4 1 OS=Homo sapiens GN=SMCHD1 PE=1 SV=2 - [SMHD1_HUMAN] Ras-related protein Rap-1b-like protein OS=Homo sapiens PE=2 SV=1 - Plasma A6NIZ1 10.87 2 184 20.91 5.48 99.1 0.879 2 20.3 0.757 1 0.625 2 17.8 1.050 2 48.6 1.058 2 73.6 5.280 2 61.2 1.755 2 91.1 [RP1BL_HUMAN] membrane Putative Golgi pH regulator C OS=Homo sapiens GN=GPR89C PE=5 SV=2 - A6NKF9 3.75 1 320 36.65 9.32 82.2 Other 1.186 2 47.0 1.270 2 17.5 1.179 2 41.2 0.993 2 55.1 0.781 2 22.2 1.859 2 132.7 1.795 1 [GPHRC_HUMAN] Putative tropomyosin alpha-3 chain-like protein OS=Homo sapiens PE=5 SV=2 - A6NL28 9.87 1 223 26.25 4.51 61.1 Cytoplasm 0.536 1 0.906 1 0.792 1 0.313 1 0.876 1 1.324 1 [TPM3L_HUMAN] Protein FAM171A2 OS=Homo sapiens GN=FAM171A2 PE=1 SV=1 - A8MVW0 1.94 1 826 87.38 8.05 63.6 Other 0.570 1 0.200 1 0.333 1 0.324 1 0.490 1 1.642 1 0.343 1 [F1712_HUMAN] Uroplakin-3b-like protein OS=Homo sapiens GN=UPK3BL PE=2 SV=1 - Plasma B0FP48 8.37 2 263 28.37 8.21 152.2 1.319 4 44.8 0.494 2 8.7 0.525 3 5.6 3.651 4 105.9 6.590 4 72.9 1.625 4 24.0 0.697 2 123.5 [UPK3L_HUMAN] membrane Alkyldihydroxyacetonephosphate synthase, peroxisomal OS=Homo sapiens Peroxisom O00116 3.8 2 658 72.87 7.34 49.1 0.800 2 4.1 1.047 2 52.8 1.288 2 87.3 0.639 2 142.2 1.358 2 112.6 1.594 2 69.7 1.359 1 GN=AGPS PE=1 SV=1 - [ADAS_HUMAN] e Kinesin-like protein KIF2A OS=Homo sapiens GN=KIF2A PE=1 SV=3 - O00139 1.56 1 706 79.90 6.68 51.4 Nucleus 1.194 2 17.7 1.049 2 17.8 1.254 2 8.8 0.886 2 10.3 1.230 1 1.111 2 0.6 [KIF2A_HUMAN] ATP-dependent RNA helicase DDX39A OS=Homo sapiens GN=DDX39A PE=1 O00148 13.35 2 427 49.10 5.68 327.9 Nucleus 1.494 3 31.9 1.067 3 44.0 1.342 3 61.3 1.206 3 23.0 1.413 3 1.1 2.217 3 11.1 1.175 3 12.9 SV=2 - [DX39A_HUMAN] Plasma O00159 7.71 8 1063 121.61 9.41 179.5 Myosin-Ic OS=Homo sapiens GN=MYO1C PE=1 SV=4 - [MYO1C_HUMAN] 0.581 10 40.3 0.370 10 53.8 0.438 10 32.8 0.334 9 84.9 0.618 10 56.3 1.729 10 45.3 0.636 10 113.7 membrane Plasma O00168 13.04 1 92 10.43 9.14 195.8 Phospholemman OS=Homo sapiens GN=FXYD1 PE=1 SV=2 - [PLM_HUMAN] 0.392 1 0.532 1 2.333 1 1.538 1 1.142 2 39.1 12.872 2 94.8 7.189 1 membrane Armadillo repeat protein deleted in velo-cardio-facial syndrome OS=Homo Plasma O00192 3.85 2 962 104.58 6.81 44.1 0.697 1 0.876 1 1.594 1 sapiens GN=ARVCF PE=1 SV=1 - [ARVC_HUMAN] membrane O00214 6.94 2 317 35.79 8.25 22.3 Galectin-8 OS=Homo sapiens GN=LGALS8 PE=1 SV=4 - [LEG8_HUMAN] Cytoplasm 1.235 2 17.6 0.257 2 64.4 0.748 2 22.0 0.529 2 210.2 0.609 2 142.9 0.821 2 963.2 Tumor necrosis factor receptor superfamily member 10A OS=Homo sapiens Plasma O00220 5.34 2 468 50.06 7.03 37.1 1.452 2 20.4 1.469 2 53.9 1.339 2 62.8 1.249 2 174.4 1.142 2 359.0 0.908 2 37.4 1.348 2 99.4 GN=TNFRSF10A PE=1 SV=3 - [TR10A_HUMAN] membrane 26S proteasome non-ATPase regulatory subunit 11 OS=Homo sapiens O00231 10.9 4 422 47.43 6.48 53.0 Cytoplasm 1.238 4 38.2 0.865 4 52.4 1.090 3 7.6 0.703 3 6.2 1.068 4 32.2 1.661 4 13.8 1.409 1 GN=PSMD11 PE=1 SV=3 - [PSD11_HUMAN] 26S proteasome non-ATPase regulatory subunit 12 OS=Homo sapiens O00232 4.61 2 456 52.87 7.65 27.7 Cytoplasm 1.239 2 8.4 1.215 2 116.2 1.917 2 81.3 0.907 2 67.1 0.956 2 186.8 1.803 2 42.8 1.733 2 73.5 GN=PSMD12 PE=1 SV=3 - [PSD12_HUMAN] Signal-regulatory protein beta-1 OS=Homo sapiens GN=SIRPB1 PE=1 SV=5 - Plasma O00241 4.27 2 398 43.18 6.52 55.7 0.658 2 7.8 0.438 2 16.6 0.848 2 13.6 0.403 2 49.2 0.518 2 2.8 0.442 2 97.4 1.160 2 21.6 [SIRB1_HUMAN] membrane Copper transport protein ATOX1 OS=Homo sapiens GN=ATOX1 PE=1 SV=1 - O00244 11.76 1 68 7.40 7.24 21.0 Cytoplasm 0.502 1 0.414 1 0.647 1 0.374 1 0.296 1 1.094 1 [ATOX1_HUMAN] Membrane-associated progesterone receptor component 1 OS=Homo sapiens Plasma O00264 17.44 2 195 21.66 4.70 160.4 1.005 3 60.9 0.866 2 126.8 0.743 2 16.5 0.490 3 14.7 1.616 2 126.2 4.441 3 72.2 0.663 1 GN=PGRMC1 PE=1 SV=3 - [PGRC1_HUMAN] membrane Transcription elongation factor SPT5 OS=Homo sapiens GN=SUPT5H PE=1 O00267 4.23 5 1087 120.92 5.06 105.8 Nucleus 1.071 6 22.8 0.772 5 50.8 0.946 6 40.2 0.815 6 38.8 2.000 6 59.9 2.074 6 49.3 1.094 4 70.6 SV=1 - [SPT5H_HUMAN] DNA fragmentation factor subunit alpha OS=Homo sapiens GN=DFFA PE=1 O00273 5.14 1 331 36.50 4.79 36.9 Cytoplasm 1.403 2 36.7 1.472 1 1.327 1 1.631 2 79.3 1.586 2 51.8 SV=1 - [DFFA_HUMAN] Chloride intracellular channel protein 1 OS=Homo sapiens GN=CLIC1 PE=1 Plasma O00299 3.73 1 241 26.91 5.17 23.6 0.833 1 0.484 1 0.843 1 0.672 1 0.743 1 0.793 1 0.616 1 SV=4 - [CLIC1_HUMAN] membrane Eukaryotic translation initiation factor 3 subunit F OS=Homo sapiens GN=EIF3F O00303 7.28 2 357 37.54 5.45 97.2 Cytoplasm 1.693 3 28.5 0.883 3 3.6 1.219 3 10.0 0.736 3 5.0 1.055 3 2.4 0.679 3 34.2 1.473 2 40.5 PE=1 SV=1 - [EIF3F_HUMAN] NEDD4-like E3 ubiquitin-protein ligase WWP2 OS=Homo sapiens GN=WWP2 O00308 1.15 1 870 98.85 7.12 39.6 Cytoplasm 0.170 1 0.252 1 0.412 1 0.287 1 0.314 1 0.367 1 0.622 1 PE=1 SV=2 - [WWP2_HUMAN] Pyruvate dehydrogenase protein X component, mitochondrial OS=Homo sapiens Mitochondr O00330 4.59 2 501 54.09 8.66 141.3 1.446 2 55.9 1.065 2 41.5 1.392 2 14.8 1.998 2 54.9 1.210 2 10.4 3.350 2 41.1 1.236 2 2.1 GN=PDHX PE=1 SV=3 - [ODPX_HUMAN] ion O00410 6.29 5 1097 123.55 4.94 121.8 Importin-5 OS=Homo sapiens GN=IPO5 PE=1 SV=4 - [IPO5_HUMAN] Cytoplasm 1.640 6 22.7 0.578 6 56.6 1.071 7 23.5 0.610 5 48.5 0.994 6 74.4 1.732 7 58.3 1.081 5 44.3 DNA-directed RNA polymerase, mitochondrial OS=Homo sapiens GN=POLRMT Mitochondr O00411 1.46 2 1230 138.53 8.98 117.8 0.938 1 0.726 1 0.938 1 1.226 1 1.515 1 3.081 1 1.465 1 PE=1 SV=2 - [RPOM_HUMAN] ion Insulin-like growth factor 2 mRNA-binding protein 3 OS=Homo sapiens O00425 5.53 2 579 63.67 8.87 110.6 Nucleus 1.588 2 82.5 0.654 1 1.111 2 33.5 1.049 2 45.5 1.001 2 23.8 1.206 2 10.5 0.503 1 GN=IGF2BP3 PE=1 SV=2 - [IF2B3_HUMAN] Dynamin-1-like protein OS=Homo sapiens GN=DNM1L PE=1 SV=2 - Plasma O00429 4.89 3 736 81.83 6.81 62.1 1.317 3 3.0 0.910 2 16.1 1.218 2 15.8 1.024 2 5.0 1.410 2 15.0 1.260 3 31.9 2.115 3 15.2 [DNM1L_HUMAN] membrane Plasma O00468 9.19 14 2045 214.71 6.40 477.0 Agrin OS=Homo sapiens GN=AGRN PE=1 SV=4 - [AGRIN_HUMAN] 1.343 16 41.1 1.503 15 50.8 0.859 14 49.6 0.777 14 45.1 1.376 15 61.3 2.676 16 70.1 1.459 11 48.7 membrane Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 OS=Homo sapiens Plasma O00469 1.63 1 737 84.63 6.71 20.0 0.397 1 0.597 1 0.873 1 0.885 1 0.596 1 0.740 1 1.877 1 GN=PLOD2 PE=1 SV=2 - [PLOD2_HUMAN] membrane Butyrophilin subfamily 3 member A1 OS=Homo sapiens GN=BTN3A1 PE=1 Plasma O00481 2.53 1 513 57.64 8.03 47.7 0.728 1 1.258 1 0.635 1 0.465 1 0.624 1 0.580 1 0.858 1 SV=3 - [BT3A1_HUMAN] membrane NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 4 OS=Homo Mitochondr O00483 37.04 3 81 9.36 9.38 55.7 1.146 4 10.7 0.918 4 99.7 1.739 4 6.5 0.711 4 60.5 0.809 5 32.6 4.211 5 41.1 1.393 4 58.3 sapiens GN=NDUFA4 PE=1 SV=1 - [NDUA4_HUMAN] ion Plasma O00515 1.74 1 517 57.10 9.67 38.7 Ladinin-1 OS=Homo sapiens GN=LAD1 PE=1 SV=2 - [LAD1_HUMAN] 1.006 1 1.236 1 1.361 1 1.457 1 2.050 1 1.108 1 membrane Pescadillo homolog OS=Homo sapiens GN=PES1 PE=1 SV=1 - O00541 2.89 2 588 67.96 7.33 60.5 Nucleus 0.655 2 9.9 0.655 2 45.9 0.744 2 65.0 0.666 2 42.6 0.705 2 132.3 1.271 2 19.8 [PESC_HUMAN] Nucleolar protein 56 OS=Homo sapiens GN=NOP56 PE=1 SV=4 - O00567 14.98 7 594 66.01 9.19 179.9 Nucleus 1.045 9 35.3 0.648 9 57.6 1.100 8 28.8 1.112 9 27.3 1.064 9 14.4 2.927 10 75.3 1.113 8 42.0 [NOP56_HUMAN] ATP-dependent RNA helicase DDX3X OS=Homo sapiens GN=DDX3X PE=1 O00571 13.6 7 662 73.20 7.18 285.6 Nucleus 0.598 12 25.5 0.346 11 43.3 0.580 11 42.6 0.584 12 14.9 0.436 12 39.3
Load more

Recommended publications
  • Transcriptome Response of High- and Low-Light-Adapted Prochlorococcus Strains to Changing Iron Availability
    Transcriptome response of high- and low-light-adapted Prochlorococcus strains to changing iron availability The MIT Faculty has made this article openly available. Please share how this access benefits you. Your story matters. Citation Thompson, Anne W et al. “Transcriptome Response of High- and Low-light-adapted Prochlorococcus Strains to Changing Iron Availability.” ISME Journal (2011), 1-15. As Published http://dx.doi.org/10.1038/ismej.2011.49 Publisher Nature Publishing Group Version Author's final manuscript Citable link http://hdl.handle.net/1721.1/64705 Terms of Use Creative Commons Attribution-Noncommercial-Share Alike 3.0 Detailed Terms http://creativecommons.org/licenses/by-nc-sa/3.0/ Title: Transcriptome response of high- and low-light adapted Prochlorococcus strains to changing iron availability Running title: Prochlorococcus response to iron stress 5 Contributors: Anne W. Thompson1, Katherine Huang1, Mak A. Saito* 2, Sallie W. Chisholm* 1, 3 10 1 MIT Department of Civil and Environmental Engineering 2 Woods Hole Oceanographic Institution – Department of Marine Chemistry and Geochemistry 3 MIT Department of Biology 15 * To whom correspondence should be addressed: E-mail: [email protected] and [email protected] Subject Category: Microbial population and community ecology 20 Abstract Prochlorococcus contributes significantly to ocean primary productivity. The link between primary productivity and iron in specific ocean regions is well established and iron-limitation of Prochlorococcus cell division rates in these regions has been 25 demonstrated. However, the extent of ecotypic variation in iron metabolism among Prochlorococcus and the molecular basis for differences is not understood. Here, we examine the growth and transcriptional response of Prochlorococcus strains, MED4 and MIT9313, to changing iron concentrations.
    [Show full text]
  • Genome-Wide Analysis of 5-Hmc in the Peripheral Blood of Systemic Lupus Erythematosus Patients Using an Hmedip-Chip
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 35: 1467-1479, 2015 Genome-wide analysis of 5-hmC in the peripheral blood of systemic lupus erythematosus patients using an hMeDIP-chip WEIGUO SUI1*, QIUPEI TAN1*, MING YANG1, QIANG YAN1, HUA LIN1, MINGLIN OU1, WEN XUE1, JIEJING CHEN1, TONGXIANG ZOU1, HUANYUN JING1, LI GUO1, CUIHUI CAO1, YUFENG SUN1, ZHENZHEN CUI1 and YONG DAI2 1Guangxi Key Laboratory of Metabolic Diseases Research, Central Laboratory of Guilin 181st Hospital, Guilin, Guangxi 541002; 2Clinical Medical Research Center, the Second Clinical Medical College of Jinan University (Shenzhen People's Hospital), Shenzhen, Guangdong 518020, P.R. China Received July 9, 2014; Accepted February 27, 2015 DOI: 10.3892/ijmm.2015.2149 Abstract. Systemic lupus erythematosus (SLE) is a chronic, Introduction potentially fatal systemic autoimmune disease characterized by the production of autoantibodies against a wide range Systemic lupus erythematosus (SLE) is a typical systemic auto- of self-antigens. To investigate the role of the 5-hmC DNA immune disease, involving diffuse connective tissues (1) and modification with regard to the onset of SLE, we compared is characterized by immune inflammation. SLE has a complex the levels 5-hmC between SLE patients and normal controls. pathogenesis (2), involving genetic, immunologic and envi- Whole blood was obtained from patients, and genomic DNA ronmental factors. Thus, it may result in damage to multiple was extracted. Using the hMeDIP-chip analysis and valida- tissues and organs, especially the kidneys (3). SLE arises from tion by quantitative RT-PCR (RT-qPCR), we identified the a combination of heritable and environmental influences. differentially hydroxymethylated regions that are associated Epigenetics, the study of changes in gene expression with SLE.
    [Show full text]
  • Proteomic Analyses Reveal a Role of Cytoplasmic Droplets As an Energy Source During Sperm Epididymal Maturation
    Proteomic analyses reveal a role of cytoplasmic droplets as an energy source during sperm epididymal maturation Shuiqiao Yuana,b, Huili Zhenga, Zhihong Zhengb, Wei Yana,1 aDepartment of Physiology and Cell Biology, University of Nevada School of Medicine, Reno, NV, 89557; and bDepartment of Laboratory Animal Medicine, China Medical University, Shenyang, 110001, China Corresponding author. Email: [email protected] Supplemental Information contains one Figure (Figure S1), three Tables (Tables S1-S3) and two Videos (Videos S1 and S2) files. Figure S1. Scanning electron microscopic images of purified murine cytoplasmic droplets. Arrows point to indentations resembling the resealed defects at the detaching points when CDs come off the sperm flagella. Scale bar = 1µm Table S1 Mass spectrometry-based identifiaction of proteins highly enriched in murine cytoplasmic droplets. # MS/MS View:Identified Proteins (105) Accession Number Molecular Weight Protein Grouping Ambiguity Dot_1_1 Dot_2_1 Dot_3_1 Dot_4_1Dot_5_1 Dot_1_2 Dot_2_2 Dot_3_2 Dot_4_2 Dot_5_2 1 IPI:IPI00467457.3 Tax_Id=10090 Gene_Symbol=Ldhc L-lactate dehydrogenase C chain IPI00467457 36 kDa TRUE 91% 100% 100% 100% 100% 100% 100% 100% 100% 2 IPI:IPI00473320.2 Tax_Id=10090 Gene_Symbol=Actb Putative uncharacterized protein IPI00473320 42 kDa TRUE 75% 100% 100% 100% 100% 89% 76% 100% 100% 100% 3 IPI:IPI00224181.7 Tax_Id=10090 Gene_Symbol=Akr1b7 Aldose reductase-related protein 1 IPI00224181 36 kDa TRUE 100% 100% 76% 100% 100% 4 IPI:IPI00228633.7 Tax_Id=10090 Gene_Symbol=Gpi1 Glucose-6-phosphate
    [Show full text]
  • A Mutation in DNA Polymerase Α Rescues WEE1KO Sensitivity to HU
    International Journal of Molecular Sciences Article A Mutation in DNA Polymerase α Rescues WEE1KO Sensitivity to HU Thomas Eekhout 1,2 , José Antonio Pedroza-Garcia 1,2 , Pooneh Kalhorzadeh 1,2, Geert De Jaeger 1,2 and Lieven De Veylder 1,2,* 1 Department of Plant Biotechnology and Bioinformatics, Ghent University, 9052 Gent, Belgium; [email protected] (T.E.); [email protected] (J.A.P.-G.); [email protected] (P.K.); [email protected] (G.D.J.) 2 Center for Plant Systems Biology, VIB, 9052 Gent, Belgium * Correspondence: [email protected] Abstract: During DNA replication, the WEE1 kinase is responsible for safeguarding genomic integrity by phosphorylating and thus inhibiting cyclin-dependent kinases (CDKs), which are the driving force of the cell cycle. Consequentially, wee1 mutant plants fail to respond properly to problems arising during DNA replication and are hypersensitive to replication stress. Here, we report the identification of the pola-2 mutant, mutated in the catalytic subunit of DNA polymerase α, as a suppressor mutant of wee1. The mutated protein appears to be less stable, causing a loss of interaction with its subunits and resulting in a prolonged S-phase. Keywords: replication stress; DNA damage; cell cycle checkpoint Citation: Eekhout, T.; Pedroza- 1. Introduction Garcia, J.A.; Kalhorzadeh, P.; De Jaeger, G.; De Veylder, L. A Mutation DNA replication is a highly complex process that ensures the chromosomes are in DNA Polymerase α Rescues correctly replicated to be passed onto the daughter cells during mitosis. Replication starts WEE1KO Sensitivity to HU. Int.
    [Show full text]
  • Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model
    Downloaded from http://www.jimmunol.org/ by guest on September 25, 2021 T + is online at: average * The Journal of Immunology , 34 of which you can access for free at: 2016; 197:1477-1488; Prepublished online 1 July from submission to initial decision 4 weeks from acceptance to publication 2016; doi: 10.4049/jimmunol.1600589 http://www.jimmunol.org/content/197/4/1477 Molecular Profile of Tumor-Specific CD8 Cell Hypofunction in a Transplantable Murine Cancer Model Katherine A. Waugh, Sonia M. Leach, Brandon L. Moore, Tullia C. Bruno, Jonathan D. Buhrman and Jill E. Slansky J Immunol cites 95 articles Submit online. Every submission reviewed by practicing scientists ? is published twice each month by Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts http://jimmunol.org/subscription Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html http://www.jimmunol.org/content/suppl/2016/07/01/jimmunol.160058 9.DCSupplemental This article http://www.jimmunol.org/content/197/4/1477.full#ref-list-1 Information about subscribing to The JI No Triage! Fast Publication! Rapid Reviews! 30 days* Why • • • Material References Permissions Email Alerts Subscription Supplementary The Journal of Immunology The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2016 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. This information is current as of September 25, 2021. The Journal of Immunology Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model Katherine A.
    [Show full text]
  • Table 2. Significant
    Table 2. Significant (Q < 0.05 and |d | > 0.5) transcripts from the meta-analysis Gene Chr Mb Gene Name Affy ProbeSet cDNA_IDs d HAP/LAP d HAP/LAP d d IS Average d Ztest P values Q-value Symbol ID (study #5) 1 2 STS B2m 2 122 beta-2 microglobulin 1452428_a_at AI848245 1.75334941 4 3.2 4 3.2316485 1.07398E-09 5.69E-08 Man2b1 8 84.4 mannosidase 2, alpha B1 1416340_a_at H4049B01 3.75722111 3.87309653 2.1 1.6 2.84852656 5.32443E-07 1.58E-05 1110032A03Rik 9 50.9 RIKEN cDNA 1110032A03 gene 1417211_a_at H4035E05 4 1.66015788 4 1.7 2.82772795 2.94266E-05 0.000527 NA 9 48.5 --- 1456111_at 3.43701477 1.85785922 4 2 2.8237185 9.97969E-08 3.48E-06 Scn4b 9 45.3 Sodium channel, type IV, beta 1434008_at AI844796 3.79536664 1.63774235 3.3 2.3 2.75319499 1.48057E-08 6.21E-07 polypeptide Gadd45gip1 8 84.1 RIKEN cDNA 2310040G17 gene 1417619_at 4 3.38875643 1.4 2 2.69163229 8.84279E-06 0.0001904 BC056474 15 12.1 Mus musculus cDNA clone 1424117_at H3030A06 3.95752801 2.42838452 1.9 2.2 2.62132809 1.3344E-08 5.66E-07 MGC:67360 IMAGE:6823629, complete cds NA 4 153 guanine nucleotide binding protein, 1454696_at -3.46081884 -4 -1.3 -1.6 -2.6026947 8.58458E-05 0.0012617 beta 1 Gnb1 4 153 guanine nucleotide binding protein, 1417432_a_at H3094D02 -3.13334396 -4 -1.6 -1.7 -2.5946297 1.04542E-05 0.0002202 beta 1 Gadd45gip1 8 84.1 RAD23a homolog (S.
    [Show full text]
  • The Regulation of Carbamoyl Phosphate Synthetase-Aspartate Transcarbamoylase-Dihydroorotase (Cad) by Phosphorylation and Protein-Protein Interactions
    THE REGULATION OF CARBAMOYL PHOSPHATE SYNTHETASE-ASPARTATE TRANSCARBAMOYLASE-DIHYDROOROTASE (CAD) BY PHOSPHORYLATION AND PROTEIN-PROTEIN INTERACTIONS Eric M. Wauson A dissertation submitted to the faculty of the University of North Carolina at Chapel Hill in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Department of Pharmacology. Chapel Hill 2007 Approved by: Lee M. Graves, Ph.D. T. Kendall Harden, Ph.D. Gary L. Johnson, Ph.D. Aziz Sancar M.D., Ph.D. Beverly S. Mitchell, M.D. 2007 Eric M. Wauson ALL RIGHTS RESERVED ii ABSTRACT Eric M. Wauson: The Regulation of Carbamoyl Phosphate Synthetase-Aspartate Transcarbamoylase-Dihydroorotase (CAD) by Phosphorylation and Protein-Protein Interactions (Under the direction of Lee M. Graves, Ph.D.) Pyrimidines have many important roles in cellular physiology, as they are used in the formation of DNA, RNA, phospholipids, and pyrimidine sugars. The first rate- limiting step in the de novo pyrimidine synthesis pathway is catalyzed by the carbamoyl phosphate synthetase II (CPSase II) part of the multienzymatic complex Carbamoyl phosphate synthetase, Aspartate transcarbamoylase, Dihydroorotase (CAD). CAD gene induction is highly correlated to cell proliferation. Additionally, CAD is allosterically inhibited or activated by uridine triphosphate (UTP) or phosphoribosyl pyrophosphate (PRPP), respectively. The phosphorylation of CAD by PKA and ERK has been reported to modulate the response of CAD to allosteric modulators. While there has been much speculation on the identity of CAD phosphorylation sites, no definitive identification of in vivo CAD phosphorylation sites has been performed. Therefore, we sought to determine the specific CAD residues phosphorylated by ERK and PKA in intact cells.
    [Show full text]
  • Proteomic Analysis of the Rad18 Interaction Network in DT40 – a Chicken B Cell Line
    Proteomic analysis of the Rad18 interaction network in DT40 – a chicken B cell line Thesis submitted for the degree of Doctor of Natural Sciences at the Faculty of Biology, Ludwig-Maximilians-University Munich 15th January, 2009 Submitted by Sushmita Gowri Sreekumar Chennai, India Completed at the Helmholtz Zentrum München German Research Center for Environmental Health Institute of Clinical Molecular Biology and Tumor Genetics, Munich Examiners: PD Dr. Berit Jungnickel Prof. Heinrich Leonhardt Prof. Friederike Eckardt-Schupp Prof. Harry MacWilliams Date of Examination: 16th June 2009 To my Parents, Sister, Brother & Rajesh Table of Contents 1. SUMMARY ........................................................................................................................ 1 2. INTRODUCTION ............................................................................................................. 2 2.1. MECHANISMS OF DNA REPAIR ......................................................................................... 3 2.2. ADAPTIVE GENETIC ALTERATIONS – AN ADVANTAGE ....................................................... 5 2.3. THE PRIMARY IG DIVERSIFICATION DURING EARLY B CELL DEVELOPMENT ...................... 6 2.4. THE SECONDARY IG DIVERSIFICATION PROCESSES IN THE GERMINAL CENTER .................. 7 2.4.1. Processing of AID induced DNA lesions during adaptive immunity .................. 9 2.5. TARGETING OF SOMATIC HYPERMUTATION TO THE IG LOCI ............................................ 10 2.6. ROLE OF THE RAD6 PATHWAY IN IG DIVERSIFICATION
    [Show full text]
  • A Minimum-Labeling Approach for Reconstructing Protein Networks Across Multiple Conditions
    A Minimum-Labeling Approach for Reconstructing Protein Networks across Multiple Conditions Arnon Mazza1, Irit Gat-Viks2, Hesso Farhan3, and Roded Sharan1 1 Blavatnik School of Computer Science, Tel Aviv University, Tel Aviv 69978, Israel. Email: [email protected]. 2 Dept. of Cell Research and Immunology, Tel Aviv University, Tel Aviv 69978, Israel. 3 Biotechnology Institute Thurgau, University of Konstanz, Unterseestrasse 47, CH-8280 Kreuzlingen, Switzerland. Abstract. The sheer amounts of biological data that are generated in recent years have driven the development of network analysis tools to fa- cilitate the interpretation and representation of these data. A fundamen- tal challenge in this domain is the reconstruction of a protein-protein sub- network that underlies a process of interest from a genome-wide screen of associated genes. Despite intense work in this area, current algorith- mic approaches are largely limited to analyzing a single screen and are, thus, unable to account for information on condition-specific genes, or reveal the dynamics (over time or condition) of the process in question. Here we propose a novel formulation for network reconstruction from multiple-condition data and devise an efficient integer program solution for it. We apply our algorithm to analyze the response to influenza in- fection in humans over time as well as to analyze a pair of ER export related screens in humans. By comparing to an extant, single-condition tool we demonstrate the power of our new approach in integrating data from multiple conditions in a compact and coherent manner, capturing the dynamics of the underlying processes. 1 Introduction With the increasing availability of high-throughput data, network biol- arXiv:1307.7803v1 [q-bio.QM] 30 Jul 2013 ogy has become the method of choice for filtering, interpreting and rep- resenting these data.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Supporting Information
    Supporting Information Figure S1. The functionality of the tagged Arp6 and Swr1 was confirmed by monitoring cell growth and sensitivity to hydeoxyurea (HU). Five-fold serial dilutions of each strain were plated on YPD with or without 50 mM HU and incubated at 30°C or 37°C for 3 days. Figure S2. Localization of Arp6 and Swr1 on chromosome 3. The binding of Arp6-FLAG (top), Swr1-FLAG (middle), and Arp6-FLAG in swr1 cells (bottom) are compared. The position of Tel 3L, Tel 3R, CEN3, and the RP gene are shown under the panels. Figure S3. Localization of Arp6 and Swr1 on chromosome 4. The binding of Arp6-FLAG (top), Swr1-FLAG (middle), and Arp6-FLAG in swr1 cells (bottom) in the whole chromosome region are compared. The position of Tel 4L, Tel 4R, CEN4, SWR1, and RP genes are shown under the panels. Figure S4. Localization of Arp6 and Swr1 on the region including the SWR1 gene of chromosome 4. The binding of Arp6- FLAG (top), Swr1-FLAG (middle), and Arp6-FLAG in swr1 cells (bottom) are compared. The position and orientation of the SWR1 gene is shown. Figure S5. Localization of Arp6 and Swr1 on chromosome 5. The binding of Arp6-FLAG (top), Swr1-FLAG (middle), and Arp6-FLAG in swr1 cells (bottom) are compared. The position of Tel 5L, Tel 5R, CEN5, and the RP genes are shown under the panels. Figure S6. Preferential localization of Arp6 and Swr1 in the 5′ end of genes. Vertical bars represent the binding ratio of proteins in each locus.
    [Show full text]
  • Cellular and Molecular Signatures in the Disease Tissue of Early
    Cellular and Molecular Signatures in the Disease Tissue of Early Rheumatoid Arthritis Stratify Clinical Response to csDMARD-Therapy and Predict Radiographic Progression Frances Humby1,* Myles Lewis1,* Nandhini Ramamoorthi2, Jason Hackney3, Michael Barnes1, Michele Bombardieri1, Francesca Setiadi2, Stephen Kelly1, Fabiola Bene1, Maria di Cicco1, Sudeh Riahi1, Vidalba Rocher-Ros1, Nora Ng1, Ilias Lazorou1, Rebecca E. Hands1, Desiree van der Heijde4, Robert Landewé5, Annette van der Helm-van Mil4, Alberto Cauli6, Iain B. McInnes7, Christopher D. Buckley8, Ernest Choy9, Peter Taylor10, Michael J. Townsend2 & Costantino Pitzalis1 1Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK. Departments of 2Biomarker Discovery OMNI, 3Bioinformatics and Computational Biology, Genentech Research and Early Development, South San Francisco, California 94080 USA 4Department of Rheumatology, Leiden University Medical Center, The Netherlands 5Department of Clinical Immunology & Rheumatology, Amsterdam Rheumatology & Immunology Center, Amsterdam, The Netherlands 6Rheumatology Unit, Department of Medical Sciences, Policlinico of the University of Cagliari, Cagliari, Italy 7Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow G12 8TA, UK 8Rheumatology Research Group, Institute of Inflammation and Ageing (IIA), University of Birmingham, Birmingham B15 2WB, UK 9Institute of
    [Show full text]